These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Studies on male sexual impotence. Report 18. Therapeutic trial with prostaglandin E1 for organic impotence]. Ishii N; Watanabe H; Irisawa C; Kikuchi Y; Kawamura S; Suzuki K; Chiba R; Tokiwa M; Shirai M Nihon Hinyokika Gakkai Zasshi; 1986 Jun; 77(6):954-62. PubMed ID: 3773397 [No Abstract] [Full Text] [Related]
10. Prostaglandin E1 in erectile dysfunction. Efficiency and incidence of priapism. Schramek P; Dorninger R; Waldhauser M; Konecny P; Porpaczy P Br J Urol; 1990 Jan; 65(1):68-71. PubMed ID: 2310934 [TBL] [Abstract][Full Text] [Related]
11. The rationale for prostaglandin E1 (alpha-alprostadil) in the management of male impotence. Porst H Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():539-44. PubMed ID: 7732903 [No Abstract] [Full Text] [Related]
12. The use of prostaglandins for diagnosis and treatment of erectile impotence. Merckx L; Vanwaeyenbergh J; De Bruyne R; Braeckman J; Keuppens F Acta Urol Belg; 1991; 59(3):47-52. PubMed ID: 1759665 [TBL] [Abstract][Full Text] [Related]
19. Double-blind, cross-over study comparing prostaglandin E1 and papaverine in patients with vasculogenic impotence. Kattan S; Collins JP; Mohr D Urology; 1991 Jun; 37(6):516-8. PubMed ID: 2038782 [TBL] [Abstract][Full Text] [Related]
20. Long-term, multicenter study of the safety and efficacy of topical alprostadil cream in male patients with erectile dysfunction. Rooney M; Pfister W; Mahoney M; Nelson M; Yeager J; Steidle C J Sex Med; 2009 Feb; 6(2):520-34. PubMed ID: 19138370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]